Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR⁺HER2^- breast cancer via CX3CR1⁺ macrophages

Giulia Petroni^#^{1

2}, Claudia Galassi^#¹, Kenneth H Gouin 3rd^#³, Hsiang-Han Chen^{3

4}, Aitziber Buqué¹, Norma Bloy¹, Takahiro Yamazaki¹, Ai Sato¹, Manuel Beltrán-Visiedo¹, Ginevra Campia¹, Carlos Jiménez-Cortegana^{1

5}, Aagam Shah³, Alexander Kirchmair⁶, Chiara Massa⁷, Claudia Wickenhauser⁸, Carlos Eduardo de Andrea⁹, Belén Navarro-Rubio¹⁰, Irantzu Serrano-Mendioroz¹¹, Esther Navarro Manzano^{12

13}, Alexandra M Satty¹⁴, Brady Rippon¹⁵, Francesca Finotello^{6

16

17}, Zlatko Trajanoski⁶, Xi Kathy Zhou¹⁵, Joseph M Scandura¹⁴, Elena García-Martínez^{13

18

19}, Francisco Ayala de la Peña^{13

18

20}, María Esperanza Rodríguez-Ruiz^{10

11}, Barbara Seliger^{7

21

22}, Víctor Sánchez-Margalet^{5

23}, Luis de la Cruz-Merino^{5

24}, Reva K Basho²⁵, Stephen L Shiao^{3

26}, Heather L McArthur²⁷, Silvia C Formenti^{28

29

30}, Simon R V Knott³¹, Lorenzo Galluzzi^{32

33

34

35}

Affiliations

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
² Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
³ Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁴ Department of Computer Science and Information Engineering, National Taiwan Normal University, Taipei, Taiwan.
⁵ Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.
⁶ Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.
⁷ Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
⁸ Institute of Pathology, University Hospital Halle, Halle, Germany.
⁹ Department of Anatomy, Physiology and Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
¹⁰ Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
¹¹ Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.
¹² Centro Regional de Hemodonación, Murcia, Spain.
¹³ Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
¹⁴ Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
¹⁵ Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
¹⁶ Department of Molecular Biology, University of Innsbruck, Innsbruck, Austria.
¹⁷ Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
¹⁸ Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.
¹⁹ Universidad Católica San Antonio de Murcia, Guadalupe, Spain.
²⁰ Universidad de Murcia, Murcia, Spain.
²¹ Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
²² Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.
²³ Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.
²⁴ Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.
²⁵ Ellison Institute of Technology, Los Angeles, CA, USA.
²⁶ Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁷ Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
²⁸ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.
²⁹ Department of Medicine, Weill Cornell Medicine, New York, NY, USA. deadoc80@gmail.com.
³⁰ Sandra and Edward Meyer Cancer Center, New York, NY, USA. deadoc80@gmail.com.
³¹ Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. formenti@med.cornell.edu.
³² Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. simon.knott@cshs.org.
³³ Sandra and Edward Meyer Cancer Center, New York, NY, USA. simon.knott@cshs.org.
³⁴ Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. simon.knott@cshs.org.
³⁵ Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. simon.knott@cshs.org.

^# Contributed equally.

PMID: 40702362
DOI: 10.1038/s43018-025-01036-8

Published Erratum

Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR⁺HER2^- breast cancer via CX3CR1⁺ macrophages

Giulia Petroni et al. Nat Cancer. 2025 Oct.

. 2025 Oct;6(10):1754.

doi: 10.1038/s43018-025-01036-8.

Authors

Affiliations

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
² Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
³ Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁴ Department of Computer Science and Information Engineering, National Taiwan Normal University, Taipei, Taiwan.
⁵ Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.
⁶ Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.
⁷ Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
⁸ Institute of Pathology, University Hospital Halle, Halle, Germany.
⁹ Department of Anatomy, Physiology and Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
¹⁰ Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
¹¹ Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.
¹² Centro Regional de Hemodonación, Murcia, Spain.
¹³ Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
¹⁴ Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
¹⁵ Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
¹⁶ Department of Molecular Biology, University of Innsbruck, Innsbruck, Austria.
¹⁷ Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
¹⁸ Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.
¹⁹ Universidad Católica San Antonio de Murcia, Guadalupe, Spain.
²⁰ Universidad de Murcia, Murcia, Spain.
²¹ Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
²² Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.
²³ Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.
²⁴ Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.
²⁵ Ellison Institute of Technology, Los Angeles, CA, USA.
²⁶ Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁷ Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
²⁸ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.
²⁹ Department of Medicine, Weill Cornell Medicine, New York, NY, USA. deadoc80@gmail.com.
³⁰ Sandra and Edward Meyer Cancer Center, New York, NY, USA. deadoc80@gmail.com.
³¹ Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. formenti@med.cornell.edu.
³² Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. simon.knott@cshs.org.
³³ Sandra and Edward Meyer Cancer Center, New York, NY, USA. simon.knott@cshs.org.
³⁴ Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. simon.knott@cshs.org.
³⁵ Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. simon.knott@cshs.org.

^# Contributed equally.

PMID: 40702362
DOI: 10.1038/s43018-025-01036-8

No abstract available

PubMed Disclaimer

Erratum for

IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR⁺HER2^- breast cancer via CX3CR1⁺ macrophages.
Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L. Petroni G, et al. Nat Cancer. 2025 Oct;6(10):1656-1675. doi: 10.1038/s43018-025-01007-z. Epub 2025 Jul 7. Nat Cancer. 2025. PMID: 40624238

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR⁺HER2^- breast cancer via CX3CR1⁺ macrophages

Affiliations

Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR⁺HER2^- breast cancer via CX3CR1⁺ macrophages

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous